HomeInsightsMarket Capitalization

Market Capitalization of Lupin Ltd

Market Capitalization of Lupin Ltd

stocks purchased

₹ 3.7 Cr

Volume Transacted

(Dec 20, 2024)

stocks purchased

17.4 K

Stocks Traded

(Dec 20, 2024)

Last Updated on: Dec 22, 2024

Image

Lupin Ltd

NSE: LUPIN

Market Cap

₹ 97970.71 crore

Last updated on: Dec 20, 2024

Key Highlights

  • The Market Cap of Lupin Ltd is ₹ 97970 crore as of 20 Dec 24 .
  • The Market Cap of Lupin Ltd changed from ₹ 33443 crore on March 2019 to ₹ 73722 crore on March 2024 . This represents a CAGR of 14.08% over 6 years.
  • The Latest Trading Price of Lupin Ltd is ₹ 2147 as of 20 Dec 15:30 .
  • The Dividend Payouts of Lupin Ltd changed from ₹ 5 on Jul 29, 2019 to ₹ 8 on Jul 16, 2024 . This represents a CAGR of 8.15% over 6 years.

Historical Market Cap of Lupin Ltd

No data available

* All values are in crore

Company Fundamentals for Lupin Ltd

No data available

Image

Lupin Ltd

NSE: LUPIN

Share Price

₹ 2147.55

-14.65 (-0.68%)

stock direction

Last updated on: Dec 20, 2024

Market Price of Lupin Ltd

1M

1Y

3Y

5Y

Monitoring Lupin Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Dec 20242147.55
19 Dec 20242162.2
18 Dec 20242098.7
17 Dec 20242045.9
16 Dec 20242062.4
13 Dec 20242075.55
12 Dec 20242117.1
11 Dec 20242149.4
10 Dec 20242134.45
09 Dec 20242106.65

SWOT Analysis Of Lupin Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Lupin Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Lupin Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Lupin Ltd

No data available

No data available

Historical P/E Ratio of Lupin Ltd

No data available

* All values are in %

Historical Revenue of Lupin Ltd

No data available

* All values are in crore

Historical EBITDA of Lupin Ltd

No data available

* All values are in crore

Historical Net Profit of Lupin Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Lupin Ltd

No data available

* All values are in

About Lupin Ltd

  • Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
  • The Company has significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporins segments. Lupin Ltd was incorporated in the year 1983 with the name Lupin Chemicals Ltd. In the year 1987, the company commenced operations in Cephalexin Plant at Mandideep and 7 ADCA plant at Ankleshwar.
  • In the year 1989, the company established a joint venture in Thailand, namely Lupin Chemicals (Thailand) Ltd.

Lupin Ltd News Hub

News

Lupin receives USFDA nod for new HIV drug

Emtricitabine and tenofovir alafenamide combination is used together with other medicines ...

Read more

19 Dec 2024 09:54

News

Lupin allots 36,979 equity shares under ESOP

Lupin has allotted 36979 fully paid-up equity shares of Rs 2/- each. These shares have bee...

Read more

19 Dec 2024 16:25

News

Lupin acquires 3 anti-diabetic drugs from Boehringer Ingelheim

GIBTULIO (empagliflozin), GIBTULIO MET (empagliflozin + metformin) and AJADUO (empaglifloz...

Read more

14 Dec 2024 10:33

News

Lupin acquires 3 anti-diabetes trademarks from Boehringer Ingelheim

Lupin announced today the acquisition of anti-diabetes trademarks GIBTULIO', GIBTULIO MET'...

Read more

13 Dec 2024 18:19

News

Lupin Ltd gains for fifth session

Lupin Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 2111.45,...

Read more

25 Nov 2024 13:00

News

Lupin allots 2642 equity shares under ESOP

Lupin allots 2642 equity shares under ESOP on 19 November 2024. In view of the above, the ...

Read more

19 Nov 2024 14:28

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Lupin Ltd Market Cap

What is the market cap of Lupin Ltd?

As of December 22, 2024, Lupin Ltd has a market capitalization of ₹97970.71, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Lupin Ltd's market capitalization?

Lupin Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Lupin Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Lupin Ltd's market capitalization change?

Lupin Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions